The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-(1-(1-((R)-1-(2,4-Dichlorophenyl)ethyl)-3-methyl-1H-pyrazolo[3,4-b]pyrazin-6-yl)azetidin-3-yl)piperidin-1-yl)-ethane-1-sulfonamide ID: ALA4649666
PubChem CID: 134210781
Max Phase: Preclinical
Molecular Formula: C24H31Cl2N7O2S
Molecular Weight: 552.53
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nn([C@H](C)c2ccc(Cl)cc2Cl)c2nc(N3CC(C4CCCN(CCS(N)(=O)=O)C4)C3)cnc12
Standard InChI: InChI=1S/C24H31Cl2N7O2S/c1-15-23-24(33(30-15)16(2)20-6-5-19(25)10-21(20)26)29-22(11-28-23)32-13-18(14-32)17-4-3-7-31(12-17)8-9-36(27,34)35/h5-6,10-11,16-18H,3-4,7-9,12-14H2,1-2H3,(H2,27,34,35)/t16-,17?/m1/s1
Standard InChI Key: JNVDHPRSSPTENB-TZHYSIJRSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
8.9093 -12.0025 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6173 -11.5953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3297 -12.0061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3297 -12.8255 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6198 -13.2362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9093 -12.8308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2003 -13.2408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9840 -14.0443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1912 -13.8331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4075 -13.0296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4822 -14.2389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4822 -15.0589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7731 -15.4688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0641 -15.0588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0641 -14.2430 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7731 -13.8331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3550 -13.8331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6460 -14.2430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9370 -13.8331 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.2279 -14.2430 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3439 -13.1222 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5281 -13.1222 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9372 -11.4576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6042 -10.7095 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7907 -10.7931 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2093 -10.2158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4209 -10.4270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4246 -9.4233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8433 -8.8415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0546 -8.0526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8475 -7.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4264 -8.4172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2179 -9.2108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0587 -7.0530 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.0508 -9.0568 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.7256 -11.6688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
6 7 1 0
8 7 1 0
9 8 1 0
9 10 1 0
10 7 1 0
11 9 1 0
11 12 1 0
13 12 1 0
14 13 1 0
15 14 1 0
16 15 1 0
11 16 1 0
15 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
19 22 2 0
3 23 1 0
24 23 2 0
25 24 1 0
2 25 1 0
25 26 1 0
26 27 1 6
26 28 1 0
29 28 2 0
30 29 1 0
31 30 2 0
32 31 1 0
33 32 2 0
28 33 1 0
31 34 1 0
29 35 1 0
23 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 552.53Molecular Weight (Monoisotopic): 551.1637AlogP: 3.49#Rotatable Bonds: 7Polar Surface Area: 110.24Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.19CX Basic pKa: 8.25CX LogP: 2.79CX LogD: 1.88Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.48Np Likeness Score: -1.34
References 1. Robles O, Jackson JJ, Marshall L, Talay O, Chian D, Cutler G, Diokno R, Hu DX, Jacobson S, Karbarz E, Kassner PD, Ketcham JM, McKinnell J, Meleza C, Reilly MK, Riegler E, Shunatona HP, Wadsworth A, Younai A, Brockstedt DG, Wustrow DJ, Zibinsky M.. (2020) Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors., 63 (15): [PMID:32667798 ] [10.1021/acs.jmedchem.0c00988 ]